FDA Clearance Tracker · K252336
Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay
Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2026
Substantially Equivalent
Time to decision
270 days
Received Jul 28, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Not stated
The decision
- FDA number
- K252336
- Device name
- Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay
- Applicant
- Diazyme Laboratories, Inc.
- Applicant location
- Poway, CA
- Received
- Jul 28, 2025
- Decided
- Apr 24, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- We could not check whether this was the first decision under its product code.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252336
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Diazyme Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253069 · Decided Jun 16, 2026 · 266 days after receipt
Device type: Lipoprotein, Low-Density, Antigen, Antiserum, Control (DFC) · Laboratory Medicine & Pathology
- Diazyme Human Kappa (k) Free Light Chain Assay; Diazyme Human Lambda (¿) Free Light Chain Assay510(k)
K253358 · Decided Dec 19, 2025 · 80 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
K243462 · Decided Aug 1, 2025 · 266 days after receipt
Device type: Assay, Porphyrin, Spectrophotometry, Lithium (NDW) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.